Using Acellular Bioactive Extracellular Matrix Scaffolds to Enhance Endogenous Cardiac Repair.

about

Using Acellular Bioactive Extracellular Matrix Scaffolds to Enhance Endogenous Cardiac Repair.

Item

http://www.wikidata.org/entity/Q55118363

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Using Acellular Bioactive Extr ...... nce Endogenous Cardiac Repair.

@en

Using Acellular Bioactive Extr ...... nce Endogenous Cardiac Repair.

@nl

type

Item

label

Using Acellular Bioactive Extr ...... nce Endogenous Cardiac Repair.

@en

Using Acellular Bioactive Extr ...... nce Endogenous Cardiac Repair.

@nl

prefLabel

Using Acellular Bioactive Extr ...... nce Endogenous Cardiac Repair.

@en

Using Acellular Bioactive Extr ...... nce Endogenous Cardiac Repair.

@nl

P1476

Using Acellular Bioactive Extr ...... nce Endogenous Cardiac Repair.

@en

P2093

Daniyil A Svystonyuk

http://www.w3.org/2001/XMLSchema#string

Holly E M Mewhort

http://www.w3.org/2001/XMLSchema#string

P2860

Distilling complexity to advance cardiac tissue engineering

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration

Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart

Mesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal Extracellular Matrix for Cardiovascular Applications

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association

Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up.

Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FCVM.2018.00035

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul W. Fedak

P577

2018-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29696148

http://www.w3.org/2001/XMLSchema#string

P932

5904207

http://www.w3.org/2001/XMLSchema#string